BioNTech to Host Innovation Series R&D Day on November 14, 2024
2024年10月31日 - 8:45PM
MAINZ, Germany, October 31,
2024 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX,
“BioNTech” or “the Company”), will host an edition of the Company’s
Innovation Series R&D Day at 10:30 a.m. Eastern Standard Time
(16:30 p.m. CET) on Thursday, November 14, 2024 in New York City,
U.S.
On the day, BioNTech’s leadership team will
provide an overview of the Company’s corporate strategy and
clinical progress across its pipeline.
Investors, analysts and the interested public
are invited to join the event online via this link.
A replay of the webcast will be available
shortly after the conclusion of the event and archived on the
Company’s website for one year following the call. The public may
also access the presentation slides via the “Events &
Presentations” page of the Investor Relations section of the
Company’s website at www.BioNTech.com.
About BioNTechBiopharmaceutical New
Technologies (BioNTech) is a global next generation immunotherapy
company pioneering novel therapies for cancer and other serious
diseases. BioNTech exploits a wide array of computational discovery
and therapeutic drug platforms for the rapid development of novel
biopharmaceuticals. Its broad portfolio of oncology product
candidates includes individualized and off-the-shelf mRNA-based
therapies, innovative chimeric antigen receptor (CAR) T cells,
several protein-based therapeutics, including bispecific immune
checkpoint modulators, targeted cancer antibodies and antibody-drug
conjugate (ADC) therapeutics, as well as small molecules. Based on
its deep expertise in mRNA vaccine development and in-house
manufacturing capabilities, BioNTech and its collaborators are
developing multiple mRNA vaccine candidates for a range of
infectious diseases alongside its diverse oncology pipeline.
BioNTech has established a broad set of relationships with multiple
global and specialized pharmaceutical collaborators, including
Biotheus, DualityBio, Fosun Pharma, Genentech, a member of the
Roche Group, Genevant, Genmab, MediLink, OncoC4, Pfizer and
Regeneron.
For more information, please visit
www.BioNTech.com.
CONTACTS
Investor RelationsMichael
HorowiczInvestors@biontech.de
Media RelationsJasmina Alatovic+49
(0)6131 9084 1513Media@biontech.de
BioNTech (NASDAQ:BNTX)
過去 株価チャート
から 10 2024 まで 11 2024
BioNTech (NASDAQ:BNTX)
過去 株価チャート
から 11 2023 まで 11 2024
